Especially, we found three genes (SPARCL1, ENG and TAL1) harboring frequently hypermethylated CpG sites within their promoters were also frequently down-regulated in lung adenocarcinoma. This evidence concerns the gene SPARCL1 and lung adenocarcinoma.